Medtronic unveils new stent graft in Europe

Medtronic has launched its Talent Abdominal Stent Graft on the new Xcelerant Hydro Delivery System on the European market. The system features a hydrophilic coating designed to aid navigation of the device through tight and tortuous arteries by reducing friction with the artery wall.

The Xcelerant Hydro Delivery System represents the seventh generation of innovation for the Talent Abdominal Stent Graft, which was introduced in Europe in April 1998, according the Minneapolis-based company.

“The Xcelerant Hydro Delivery System is a significant innovation that will make endovascular repair using the Talent Stent Graft a treatment option for more patients with abdominal aortic aneurysms,” said Dierk Scheinert, MD, PhD, of Park-Hospital and University of Leipzig – Heartcenter in Germany, and the leader of the first team to implant the device using the new delivery system.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.